Clinical trial
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With…
NCT06147232 · Steno Diabetes Center Copenhagen, Other · Not yet recruiting
Key facts
| NCT number | NCT06147232 |
|---|---|
| Title | Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia |
| Official title | Prevention of CKD Progression in Type 1 Diabetes With Long Term Use of SGLTi Avoiding Kidney hypOxia(PLUTO) |
| Acronym | PLUTO |
| Lead sponsor | Steno Diabetes Center Copenhagen, Other |
| Collaborators | Juvenile Diabetes Research Foundation King's College London Glostrup University Hospital, Copenhagen Guy's and St Thomas' NHS Foundation Trust |
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nephropathy, Diabetic Nephropathies, Diabetes Mellitus, Type 1, Albuminuria, Diabetic Complications Renal, Diabetic Complications Cardiovascular, Hypoxia |
| Intervention type | Drug |
| Interventions | Sotagliflozin, Placebo |
| Enrollment | 69 |
| Start date | Feb 1, 2025 |
| Primary completion | May 1, 2027 |
| Completion | May 1, 2027 |
| First posted | Nov 27, 2023 |
| Last update posted | Jan 27, 2025 |
| Countries | Denmark, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: